1.0Oct 6, 2014Anonymous employeeFormer employeeRecommendCEO approvalBusiness outlookProsThe company closed its US Operation.ConsLack of understanding of FDA by parent company in Australia.Show more
5.0Oct 18, 2023Quality control analystCurrent employeeRecommendCEO approvalBusiness outlookProsGood team and good managers, very flexibleConsOld systems, no bonus, no career opportunitiesShow moreHelpfulShare
5.0Sep 30, 2021Research scientistCurrent employee, more than 1 yearSydneyRecommendCEO approvalBusiness outlookProsCompany is the perfect size to be nimble and explorative. Staff are experienced throughout the drug development process. Senior management is well rounded, fair and knowledgeableConsDon't have any serious issuesShow moreHelpfulShare